Dr Suneel Udani unfolds how one patient’s struggle with deteriorating IgA nephropathy now inspires hope as new therapies ...

Dr Suneel Udani recounts a young mother’s experience with new therapies that lowered proteinuria, stabilized/improved kidney ...

Explore the evolution of IgA nephropathy treatment, highlighting new guidelines and targeted therapies that improve patient ...

Medically reviewed by David Ozeri, MD IgA nephropathy can be diagnosed with a combination of a physical exam, symptom assessment, medical history review, and special tests.The tests that can confirm ...

Medically reviewed by Matthew Wosnitzer, MD Signs and symptoms of IgA nephropathy vary among individuals and may not manifest ...

In the past week, Wolfe Research upgraded Vertex Pharmaceuticals from “Peer Perform” to “Outperform,” citing growing ...

Atacicept, a novel dual inhibitor of BAFF and APRIL, receives FDA Priority Review for IgA nephropathy treatment in adults.

Explore the evolution of IgA nephropathy treatment, highlighting new guidelines and targeted therapies that improve patient outcomes.

PRINCETON, N.J. & TOKYO--(BUSINESS WIRE)--Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka Pharmaceutical, Co. Ltd. (Otsuka) announce the decision to submit a Biologics ...

FDA assigned PDUFA target action date of July 7, 2026.If approved, atacicept would be the first B cell modulator targeting ...

HOUSTON -- A novel self-administered shot that inhibits two key immunoregulatory cytokines reduced proteinuria in patients with IgA nephropathy, interim findings from the phase III ORIGIN 3 trial ...

Immunoglobulin A (IgA) nephropathy is an autoimmune condition that causes inflammation and damage in your kidneys, which may lead to kidney failure over time. IgA nephropathy develops when IgA builds ...